Can Injectable Testosterone Or Deca Cause Hepatic Adenomas?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A member asks whether injectable testosterone or Deca can cause hepatic adenomas, and Dr. O’Connor explains why these benign liver masses are more strongly associated with 17-alpha-alkylated oral steroids.

02:00

Dr. O’Connor recommends specialist liver evaluation with a gastroenterologist and discusses ultrasound, CT, or MRI while emphasizing the importance of reviewing oral steroid exposure, medications, alcohol, and hepatitis history.

Video Summary

A member asks whether injectable testosterone or Deca can cause hepatic adenomas. Dr. O’Connor explains that these benign liver masses are much more strongly associated with 17-alpha-alkylated oral anabolic steroids and can also occur in people with other medication exposures or spontaneously.

He emphasizes that a suspected hepatic adenoma requires proper evaluation because not every liver mass represents the same condition or level of risk. Dr. O’Connor recommends seeing a gastroenterologist with liver expertise and discusses ultrasound, CT, or MRI as possible imaging tools used during the workup.

Dr. O’Connor does not consider injectable testosterone or Deca direct causes of hepatic adenomas, although a complicated history involving excessive androgen doses, prior oral steroid use, other medications, alcohol, or liver disease can make the overall picture more difficult to interpret.

Drug Callouts

Testosterone

Injectable testosterone is specifically questioned as a possible cause of hepatic adenomas. Dr. O’Connor says he does not consider injectable testosterone a direct cause, while acknowledging that excessive androgen exposure can complicate an individual’s broader liver-health history.

Deca-Durabolin (Nandrolone Decanoate)

Deca is specifically discussed alongside injectable testosterone when evaluating hepatic adenoma risk. Dr. O’Connor says he does not consider Deca a direct cause of these liver tumors and contrasts it with 17-alpha-alkylated oral anabolic steroids.

17-Alpha-Alkylated Oral Anabolic Steroids

Dr. O’Connor identifies 17-alpha-alkylated oral anabolic steroids as the androgen category much more strongly associated with hepatic adenomas. A history of oral steroid exposure is therefore important when evaluating a liver mass in someone who also uses testosterone or other injectable androgens.

Condition Callouts

Hepatic Adenoma

A hepatic adenoma is described as a benign liver tumor that requires proper evaluation to determine exactly what type of liver mass is present and whether it poses meaningful risk. Dr. O’Connor associates these lesions more strongly with oral 17-alpha-alkylated anabolic steroids than with injectable testosterone or Deca.

Key Takeaways

Dr. O’Connor does not consider injectable testosterone or Deca direct causes of hepatic adenomas.
17-alpha-alkylated oral anabolic steroids are much more strongly associated with hepatic adenomas than injectable testosterone preparations.
A suspected hepatic adenoma should be evaluated by a gastroenterologist with liver expertise rather than assumed to be harmless.
Ultrasound, CT, or MRI may be used to characterize a liver mass and determine what further evaluation is needed.
Oral steroid exposure, other medications, alcohol use, hepatitis history, and the complete medical history all matter when evaluating a liver lesion.